Arkolith/Insider Trading/TMCI/Form 4

Scanlan Sean F.

Chief Innovation OfficerTREACE MEDICAL CONCEPTS, INC. (TMCI) · full profile →Form 4 · filed Mar 19, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$399K
Net Open-Market Flow
-$399K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 17, 2025Sell(S)50K$7.97$399K364K
Mar 17, 2025Option exercise(M)50K$1.05$53K414K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 17, 2025Option exercise(M)50K—$017K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-042291) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML